CoChat

Estrogen Replacement in Women of Fertile Years with Hypopituitarism

Mah, P. M., Webster, J., Jönsson, P., Feldt-Rasmussen, U., Koltowska-Häggström, M., Ross, R. J. M. · 2005 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

BACKGROUND: What form of estrogen to prescribe a young hypopituitary woman with gonadal failure remains an open question despite evidence that oral estrogen therapy induces GH resistance and an increase in fat mass. METHODS: Using an international surveillance study of hypopituitary patients, we examined two questions: 1) What estrogen is prescribed to young women of fertile years with hypopituitarism? 2) Is there a difference in body composition or IGF-I levels dependent on the type of estrogen prescribed? RESULTS: Six hundred twenty-eight GH-deficient women, aged 18-50 yr, were identified. Three hundred thirteen had normal gonadal function, and 315 were receiving estrogen therapy; of these 14% were using transdermal estradiol, and 86% were taking an oral estrogen preparation (38% oral estradiol, 18% conjugated estrogens, and 30% ethinyl estradiol in the oral contraceptive). There was no difference in weight, waist/hip ratio, or body composition between the women taking different estrogen therapies. However, if the oral estrogen groups were combined, they showed less change in waist and hip measurement and had a greater waist/hip ratio after 1 yr of GH treatment compared with patients with normal gonadal function (0.85 vs. 0.83; P = 0.022). Patients taking ethinyl estradiol had lower age-adjusted IGF-I sd scores and required almost twice the GH dose to achieve an IGF-I sd score that remained lower than patients with normal gonadal function and patients receiving transdermal estradiol. CONCLUSIONS: 1) The majority of women of fertile years with hypo-pituitarism take oral estrogen replacement therapy. 2) Waist/hip ratio was greater in women taking oral estrogens, and there is indirect evidence that oral estrogens reduce the action of GH on fat mass. 3) Patients using the oral contraceptive had lower IGF-I levels and required twice the GH dose compared with patients receiving transdermal estradiol.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2005-1207

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Cited by

See all 57

Metadata

Authors
Mah, P. M., Webster, J., Jönsson, P., Feldt-Rasmussen, U., Koltowska-Häggström, M., & Ross, R. J. M.
Affiliations
  • University of Sheffield (GB)
  • Pfizer (Sweden) (SE)
  • Uppsala University (SE)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2005-11
Volume
90
Issue
11
Pages
5964-5969
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2105479197
Cited by
57
References
31
Citations by year
2024: 2 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 2 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 3
FWCI
3.08
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
estrogen replacement therapy, hypopituitarism, growth hormone deficiency, young women, transdermal estradiol, oral estrogen, ethinyl estradiol, oral contraceptives, insulin-like growth factor I, body composition, waist-to-hip ratio, fat mass, growth hormone dose
MeSH terms
Adolescent, Adult, Body Composition, Body Weight, Female, Humans, Hypopituitarism, Insulin-Like Growth Factor I, Middle Aged, Growth Hormone, Estrogen Replacement Therapy, Body Mass Index, Waist-Hip Ratio

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estrogen Replacement in Women of Fertile Years with Hypopituitarism. https://app.cochat.ai/papers/10.1210/jc.2005-1207
The paper
Mah, P. M., Webster, J., Jönsson, P., Feldt-Rasmussen, U., Koltowska-Häggström, M., & Ross, R. J. M. (2005). Estrogen Replacement in Women of Fertile Years with Hypopituitarism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2005-1207

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.